Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Collegium Pharmaceutical is a biopharmaceutical company focused on developing and commercializing differentiated products for serious medical conditions, including pain management and ADHD. Its portfolio features abuse-deterrent opioids, ADHD stimulants, and treatments for opioid-induced constipation. The company emphasizes innovative formulations, regulatory compliance, and intellectual property protection, serving healthcare providers and patients in the U.S. through a direct sales force and strategic licensing agreements.
This description was generated via AI from an annual report. Updated about 1 year ago.